Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Mautner

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|November 25, 2003
Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza virusesFalk Nimmerjahn, Dieter Kobelt, Alexander Steinkasserer, et al.
Transplantation|August 31, 2010
Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantationSlavoljub Milosevic, Barbara Bachnick, Karzan Karim, et al.
Leukemia|June 22, 2018
Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivoViktor Schneidt, Marta Ilecka, Peter Dreger, et al.
European Journal of Immunology|May 6, 2003
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagyFalk Nimmerjahn, Slavoljub Milosevic, Uta Behrends, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2015
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteinsGijsbert P van Nierop, Josef Mautner, Johanna G Mitterreiter, et al.
Blood|January 9, 2015
Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cellsXiaojun Yu, Marta Ilecka, Emmalene J Bartlett, et al.
Plos One|October 17, 2013
Targeting c-MYC with T-cellsFlorian Helm, Thomas Kammertoens, Frank M Lehmann, et al.
Plos One|July 6, 2007
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyDinesh Adhikary, Uta Behrends, Heike Boerschmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 2010
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumorsAnna Merlo, Riccardo Turrini, Sara Bobisse, et al.
European Journal of Immunology|August 13, 2004
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cellsJosef Mautner, Dagmar Pich, Falk Nimmerjahn, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|November 25, 2003
Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza virusesFalk Nimmerjahn, Dieter Kobelt, Alexander Steinkasserer, et al.
Transplantation|August 31, 2010
Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantationSlavoljub Milosevic, Barbara Bachnick, Karzan Karim, et al.
Leukemia|June 22, 2018
Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivoViktor Schneidt, Marta Ilecka, Peter Dreger, et al.
European Journal of Immunology|May 6, 2003
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagyFalk Nimmerjahn, Slavoljub Milosevic, Uta Behrends, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2015
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteinsGijsbert P van Nierop, Josef Mautner, Johanna G Mitterreiter, et al.
Blood|January 9, 2015
Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cellsXiaojun Yu, Marta Ilecka, Emmalene J Bartlett, et al.
Plos One|October 17, 2013
Targeting c-MYC with T-cellsFlorian Helm, Thomas Kammertoens, Frank M Lehmann, et al.
Plos One|July 6, 2007
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyDinesh Adhikary, Uta Behrends, Heike Boerschmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 2010
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumorsAnna Merlo, Riccardo Turrini, Sara Bobisse, et al.
European Journal of Immunology|August 13, 2004
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cellsJosef Mautner, Dagmar Pich, Falk Nimmerjahn, et al.
Pageof 8